Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirotaka Iwase

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 15, 2006
[Predictive factors of hormonal therapy in breast cancer]Hirotaka Iwase
Nihon Geka Gakkai Zasshi|October 3, 2007
[Practical use of a guideline for examination and treatment for breast cancer]Hirotaka Iwase
Breast Cancer (Tokyo, Japan)|May 9, 2003
Molecular action of the estrogen receptor and hormone dependency in breast cancerHirotaka Iwase
Breast Cancer (Tokyo, Japan)|September 24, 2008
Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancerHirotaka Iwase
International Journal of Clinical Oncology|October 24, 2008
Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancerYutaka Yamamoto, Hirotaka Iwase
Breast Cancer (Tokyo, Japan)|December 3, 2002
The role of Stat5 in estrogen receptor-positive breast cancerHiroko Yamashita, Hirotaka Iwase
Breast Cancer (Tokyo, Japan)|June 10, 2009
Triple negative breast cancer: clinicopathological characteristics and treatment strategiesFutoshi Akiyama, Hirotaka Iwase
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
dPCR Mutational Analyses in Cell-Free DNA: A Comparison with TissuesTakashi Takeshita, Hirotaka Iwase
Cancer Science|January 23, 2015
Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspectsYoko Omoto, Hirotaka Iwase
Breast Cancer (Tokyo, Japan)|January 14, 2004
p33ING1b and estrogen receptor (ER) alphaTatsuya Toyama, Hirotaka Iwase
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 15, 2006
[Predictive factors of hormonal therapy in breast cancer]Hirotaka Iwase
Nihon Geka Gakkai Zasshi|October 3, 2007
[Practical use of a guideline for examination and treatment for breast cancer]Hirotaka Iwase
Breast Cancer (Tokyo, Japan)|May 9, 2003
Molecular action of the estrogen receptor and hormone dependency in breast cancerHirotaka Iwase
Breast Cancer (Tokyo, Japan)|September 24, 2008
Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancerHirotaka Iwase
International Journal of Clinical Oncology|October 24, 2008
Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancerYutaka Yamamoto, Hirotaka Iwase
Breast Cancer (Tokyo, Japan)|December 3, 2002
The role of Stat5 in estrogen receptor-positive breast cancerHiroko Yamashita, Hirotaka Iwase
Breast Cancer (Tokyo, Japan)|June 10, 2009
Triple negative breast cancer: clinicopathological characteristics and treatment strategiesFutoshi Akiyama, Hirotaka Iwase
Methods in Molecular Biology (Clifton, N.J.)|December 24, 2018
dPCR Mutational Analyses in Cell-Free DNA: A Comparison with TissuesTakashi Takeshita, Hirotaka Iwase
Cancer Science|January 23, 2015
Clinical significance of estrogen receptor β in breast and prostate cancer from biological aspectsYoko Omoto, Hirotaka Iwase
Breast Cancer (Tokyo, Japan)|January 14, 2004
p33ING1b and estrogen receptor (ER) alphaTatsuya Toyama, Hirotaka Iwase
Pageof 15